RECOMMENDATION(S):
APPROVE and AUTHORIZE the Purchasing Agent to execute, on behalf of the Health Services Director, a Purchase Order with Curascript, Inc., in an amount not to exceed $500,000 for the hormone implant Nexplanon to be used at the Contra Costa Regional Medical Centers and Martinez Detention Centers, for the period from December 1, 2018 through November 30, 2019.
FISCAL IMPACT:
100% funding is included in the Hospital Enterprise Fund I Budget.
BACKGROUND:
Curascript, Inc. is a pharmaceutical company that provides Contra Costa Regional Medical Center and Martinez Detention Center with hormone implant Nexplanon to be used in the Obstetrics/Gynecology Unit.
CONSEQUENCE OF NEGATIVE ACTION:
If this Purchase Order is not approved, we will not be able to purchase Nexplanon for our patient population at Contra Costa Regional Medical Center and Health Clinics.
|